Antithymocyte globulin may reduce transplant related mortality and chronic GVHD in patients undergoing allogeneic stem cell transplantation.

被引：0
|
作者：
Neumeister, P [1 ]
Zinke, W [1 ]
Schmidt, HH [1 ]
Linkesch, W [1 ]
机构：
[1] Graz Univ, Dept Internal Med, Div Hematol, A-8010 Graz, Austria
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
313
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [1] Clinical impact of antithymocyte globulin in mulitple myeloma patients undergoing allogeneic stem cell transplantation.
    Ayuk, F. A.
    Perez-Simon, J. A.
    Shimoni, A.
    Sureda, A.
    Schwerdtfeger, R.
    Martino, R.
    Sayer, H. G.
    Alegre, A.
    Lahuerta, J.
    Atanackovic, D.
    Wolschke, C.
    Nagler, A.
    Zander, A.
    Miguel, J. F. San
    Kroger, N.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 86 - 86
  • [2] Antithymocyte globulin may reduce chronic graft versus host disease in patients undergoing unrelated peripheral stem cell transplantation
    Neumeister, P
    Zinke, W
    Sill, H
    Linkesch, W
    ONKOLOGIE, 1999, 22 (06): : 519 - 519
  • [3] Hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic stem cell transplantation and antithymocyte globulin treatment
    Ecsedi, M.
    Schmohl, J.
    Zeiser, R.
    Drexler, B.
    Halter, J.
    Medinger, M.
    Duyster, J.
    Kanz, L.
    Passweg, J.
    Finke, J.
    Bethge, W.
    Lengerke, C.
    Oncology Research and Treatment, 2015, 38 : 262 - 262
  • [4] COULD PROPHYLACTIC ANTITHYMOCYTE GLOBULIN BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION REDUCE RISK OF PULMONARY GVHD IN ADULT PATIENTS WITH ACUTE LEUKEMIA?
    Liao, X. -W.
    Lin, C. -T.
    Yao, M.
    Li, C. -C.
    Ko, B. -S.
    Huang, S. -Y.
    Wu, S. -J.
    Liu, J. -H.
    Tang, J. -L.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S77 - S78
  • [5] Transplant related mortality in older adults undergoing autologous stem cell transplantation.
    Klepin, HD
    Harish, V
    Keung, Y
    Hurd, D
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S152 - S152
  • [6] Impact of antithymocyte globulin induced hyperbilirubinemia on outcome of patients undergoing allogeneic hematopoietic stem cell transplantation
    Manjara, I.
    Zabelina, T.
    Bacher, U.
    Kroeger, N.
    Zander, A. R.
    Ayuk, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S403 - S403
  • [7] Impact of antithymocyte globulin on new HLA groups for unrelated donor allogeneic stem cell transplantation.
    Lee, Yoo Jin
    Kim, Jong Gwang
    Lee, Soo Jung
    Kang, Byung Woog
    Chae, Yee Soo
    Moon, Joon Ho
    Sohn, Sang Kyun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation
    Ayuk, Francis
    Diyachenko, Galina
    Zabelina, Tatjawa
    Wolschke, Christine
    Fehse, Boris
    Bacher, Ulrike
    Erttmann, Rudolf
    Kroeger, Nicolaus
    Zander, Axel R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (08) : 913 - 919
  • [9] Horsies and Bunnies: A Comparison of Antithymocyte Globulin in Allogeneic Stem Cell Transplant
    Lu, Crystal
    Neme, Klodiana
    Mikulandric, Nancy
    Grycki, Meredith
    Pelland, Danielle
    Farhan, Shatha
    Janakiraman, Nalini
    Peres, Edward
    Vogel, Vishnuprabha
    Szandzik, Ed
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S287 - S288
  • [10] Validation of a transplant-related mortality (TRM) risk score for pediatric patients undergoing allogeneic haematopoietic stem cells transplantation.
    Angelini, P.
    Gassas, A.
    Zaidman, I.
    Doyle, J.
    Schechter, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345